We announced today that we have been granted CLIA Waiver from the U.S. Food and Drug Administration (FDA), applying to our Sofia® 2 SARS Antigen+ FIA. Read the press release here: businesswire.com/news/home/2023…. #QuidelOrtho

Wally R. Smith, MD, a seasoned implementation scientist and SCD expert, explores the vital roles of clinicians and labs in screening and managing hyperhemolysis in SCD patients. Listen here: quidel.link/pod-HHS #SCD #Hyperhemolysis #WallyRSmithMD #Healthcare

Learn how automation can transform your lab's performance in healthcare. Aaron Hurst's insights have boosted efficiency, safety, and lean management at Newton Medical Center. Listen here: go.orthoclinicaldiagnostics.com/global/en/reso… #LabAutomation #AaronHurst #Healthcare

Today, we announced financial results for the third quarter ended October 1, 2023 - ir.quidelortho.com. A replay will be available shortly after the event on the on ir.quidelortho.com, under the “Events & Presentations” section. #QuidelOrtho

Members of our management team are scheduled to participate in the Evercore ISI conference in Miami, FL, on Nov. 30. Douglas Bryant, President and CEO, will participate in a fireside chat scheduled for 9:10 a.m. ET / 6:10 a.m. PT. #QuidelOrtho businesswire.com/news/home/2023…

Explore the intricacies of diagnosing herpes simplex virus (HSV), a prevalent cause of cutaneous and mucocutaneous lesions. Discover the pivotal role of molecular diagnostics in HSV management with Lori Henderson. ow.ly/WCp950Qa4g6 #HSV #Herpes #MolecularDiagnostics

We are thrilled to announce the launch of our new global corporate website. Significant enhancements make our customer-centric QuidelOrtho.com a powerful experience for all. #QuidelOrtho QuidelOrtho.com

We announced today that we have received 510(K) clearance from the @U.S.FDA for our innovative Savanna® Multiplex Molecular Platform and the Savanna® HSV 1+2/VZV Assay. businesswire.com/news/home/2023… #QuidelOrtho #HSV #VZV QuidelOrtho.com

Dr. Bijal Parikh discusses his article “Laboratory strategies for diagnosis and monitoring of hepatitis C virus infection” in the Clinical Microbiology Newsletter. ow.ly/4Zbf50Qlim4 #QuidelOrtho #QuidelOrthoScienceBytes #hepatitis #podcast #hepatitisC #HCV #bijalparikh

Looking for a summer internship in CA, NJ or NY? Our Summer Intern Program – a 12-week program starting May 20 or June 17 designed to prepare and develop our future workforce. Exciting times at QuidelOrtho! Learn more at careers.quidelortho.com/global/en/sear…. #Hiring #SummerIntern #QuidelOrtho

We announced today that we received Health Canada approval for the Triage® PLGF Test for laboratory use in Canada. businesswire.com/news/home/2024…. #QuidelOrtho #PLGF #Triage

We’ve received 510(k) clearance for our QuickVue COVID-19 test, helping ensure continued testing capabilities now and after EUA expiration. businesswire.com/news/home/2024… #QuidelOrtho quickvueathome.com quidelortho.com

We've added the ARK™ Fentanyl II Assay to our U.S. Vitros® XT 7600 and 5600 as well as our Vitros® 4600 menu of assays as an MPA. Learn more in our press release: businesswire.com/news/home/2024… and at quidelortho.com. #QuidelOrtho #MPA #Vitros #Fentanyl

We are pleased to welcome our new president and CEO, Brian Blaser. businesswire.com/news/home/2024… #QuidelOrtho

We have opened a second U.S. distribution center in Pedricktown, New Jersey, and also created new greener packaging that reduces waste and supports environmental stewardship. businesswire.com/news/home/2024… #QuidelOrtho #Distribution #ReducingWaste

Learn about real-world quality experienced by Vitros customers from this peer-reviewed Sigma study by our own Johanna Miller. And join her at McCormick Place Conventions Center on July 30, 2:45-3:45 p.m. #HealthcareQuality #SixSigma #ADLM2024

#GravesDisease, a common cause of #hyperthyroidism, is more prevalent among Black Americans. Testing disparities and later diagnosis often lead to increased rates of surgery. Learn the importance of early detection and screening on BlackDoctor.

QuidelOrtho receives 510(k) U.S. FDA clearance for its VITROS syphilis assay on the VITROS 3600 Immunodiagnostics System and VITROS 5600 and XT 7600 Integrated Systems. businesswire.com/news/home/2024…. To learn more, visit: quidelortho.com/global/en/reso…

#Menopause brings challenges but also health and wellness opportunities. QuidelOrtho’s Jeff Houtz shares how nutrition, exercise, and mental health practices can help manage symptoms. Discover more in his interview with Authority Magazine medium.com/authority-maga…

We are thrilled to announce Lee Bowman has joined our team as the new Chief Human Resources Officer. Welcome to the team, Lee! businesswire.com/news/home/2024… #Leadership #HR #TalentManagement #DiversityAndInclusion #WorkplaceCulture #WelcomeAboard